Optimizing Needle Thoracostomy in Obese Patients: Chest Wall Thickness Influences on Site Selection and Needle Length

Highlight

1. Chest wall thickness (CWT) varies significantly between anatomical sites used for needle thoracostomy in obese patients.
2. The second intercostal space at the midclavicular line (ICS 2-MCL) has significantly lower CWT than the fourth/fifth intercostal space at the anterior axillary line (ICS 4/5-AAL).
3. Increasing BMI leads to greater increases in CWT at ICS 4/5-AAL compared to ICS 2-MCL.
4. Standard needle lengths may be insufficient at certain sites in patients with class II/III obesity, impacting procedural success and suggesting tailored site and needle selection.

Study Background

Tension pneumothorax is a life-threatening complication often encountered in trauma and emergency settings. Needle thoracostomy, the insertion of a large-bore needle into the pleural space to relieve intrathoracic pressure, is a critical, time-sensitive intervention. Conventionally, the second intercostal space at the midclavicular line (ICS 2-MCL) is recommended as the primary site for needle insertion. However, in recent years, the growing prevalence of obesity has highlighted challenges in this approach due to increased chest wall thickness, which may impede needle reach into the pleural space and reduce the procedure’s effectiveness.

Alternative anatomical sites such as the fourth or fifth intercostal space at the anterior axillary line (ICS 4/5-AAL) have been proposed. Yet, the impact of obesity on chest wall thickness at these sites is less well characterized, and optimal needle length recommendations remain unclear. This knowledge gap poses a clinical risk, as inadequate needle length or site selection may lead to failed decompression and adverse patient outcomes.

Study Design

This prospective cross-sectional study enrolled 110 adult patients with class II and III obesity (Body Mass Index [BMI] range: 36 to 71 kg/m²). Chest wall thickness was measured using ultrasound imaging at two anatomical locations typically used for needle thoracostomy: the ICS 2-MCL and the ICS 4/5-AAL. The primary objective was to compare chest wall thickness between these sites across different BMI strata.

Measurements involved direct ultrasound assessment of the distance from the skin surface to the pleural line. The study employed linear mixed-effects modeling to evaluate the effects of BMI, site location, and sex on chest wall thickness. The proportion of patients whose chest wall thickness exceeded common commercially available needle lengths (50 mm standard needle and 83 mm longer needle) was also calculated for each site.

Key Findings

The study demonstrated that chest wall thickness was consistently greater at the ICS 4/5-AAL compared to ICS 2-MCL throughout the BMI range assessed. Specifically, the effect of increasing BMI on chest wall thickness was significantly more pronounced at ICS 4/5-AAL—thickness increased by approximately 11.3 mm for each 10 kg/m² rise in BMI—compared to an increase of 4.2 mm per 10 kg/m² at ICS 2-MCL.

When evaluating the risk of insufficient needle length, 22% of patients had a chest wall thickness greater than 50 mm at ICS 2-MCL, whereas this proportion rose dramatically to 82% at ICS 4/5-AAL. Notably, none of the patients exceeded 83 mm chest wall thickness at ICS 2-MCL, suggesting that an 83 mm needle would reliably penetrate the pleura at this site in obese individuals. Conversely, 21% of patients had CWT exceeding 83 mm at ICS 4/5-AAL, indicating potential failure of even longer needles at this location in a substantial minority of cases.

Sex-based differences were evaluated but not highlighted as significantly affecting site-specific chest wall thickness beyond BMI influences.

Expert Commentary

This study provides valuable evidence guiding emergency clinicians in selecting the optimal site and needle length for thoracostomy in obese patients. The utilization of ultrasound to measure chest wall thickness strengthens the methodological quality by enabling precise, non-invasive anatomic assessment rather than relying on external estimates or cadaveric data.

The findings favor the traditional ICS 2-MCL site over ICS 4/5-AAL in patients with significant obesity, due to thinner chest wall and lower variability with increasing BMI. This conclusion aligns logically with the underlying anatomical differences in soft tissue and musculature distribution. However, it challenges recent trends advocating for ICS 4/5 sites due to concerns about potential complications at ICS 2-MCL (e.g., injury to internal mammary vessels).

Limitations include the single-center design, lack of functional procedural outcome data, and potential operator variability in ultrasound measurements. Additionally, patient positioning and respiratory phase could influence measurements and were not extensively detailed. Further large multicenter studies or trials incorporating procedural success rates could enhance generalizability and clinical applicability.

Conclusion

In patients with class II/III obesity, chest wall thickness is substantially greater at the anterior axillary line (ICS 4/5-AAL) than at the midclavicular line (ICS 2-MCL), with a more pronounced increase correlating with rising BMI. No patients exceeded an 83 mm chest wall thickness at ICS 2-MCL, supporting the use of needles of this length at this site for effective pleural decompression. Conversely, longer needle lengths may be needed or procedural alternatives considered at ICS 4/5-AAL to address the higher proportion of individuals with excessive chest wall thickness.

These results underscore the importance of individualized assessment of chest wall anatomy in obese patients requiring needle thoracostomy. Integration of point-of-care ultrasound in emergency settings may optimize site and needle length selection, improving success rates and patient outcomes.

Funding and ClinicalTrials.gov

The original study did not specify funding sources. The trial was not registered in ClinicalTrials.gov as per available data.

References

1. Schaefer L, Stein E, Schwarz A, Beck G, Krebs J, Boesing C. Needle Thoracostomy: Implications of Chest Wall Thickness for Anatomical Location and Needle Length. Ann Emerg Med. 2026 Jul; [PMID: 42383960].
2. Kesieme EB, Essu IS, Irekpita E, Jebbin NJ, Nmadu PT, Dongo AE. Needle Thoracostomy: A Review of Current Practices and Recommendations. J Emerg Trauma Shock. 2016 Apr-Jun;9(2):71-73.
3. Ball CG, Kirkpatrick AW, Feliciano DV. Thoracic decompression by needle thoracostomy: Validity of the current teaching in trauma care. J Trauma. 2007;62(4):1157-1161.
4. Deakin CD, Lim S, Wright C, et al. Needle thoracostomy: is 5 cm enough? Emerg Med J. 2010 Jan;27(1):44-47.